These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 15618526)

  • 1. Quasi-likelihood estimation for relative risk regression models.
    Carter RE; Lipsitz SR; Tilley BC
    Biostatistics; 2005 Jan; 6(1):39-44. PubMed ID: 15618526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bayesian variable selection method for censored survival data.
    Faraggi D; Simon R
    Biometrics; 1998 Dec; 54(4):1475-85. PubMed ID: 9883546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using the jackknife for estimation in log link Bernoulli regression models.
    Lipsitz SR; Fitzmaurice GM; Arriaga A; Sinha D; Gawande AA
    Stat Med; 2015 Feb; 34(3):444-53. PubMed ID: 25388125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Almost efficient estimation of relative risk regression.
    Fitzmaurice GM; Lipsitz SR; Arriaga A; Sinha D; Greenberg C; Gawande AA
    Biostatistics; 2014 Oct; 15(4):745-56. PubMed ID: 24705141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relative risk regression: reliable and flexible methods for log-binomial models.
    Marschner IC; Gillett AC
    Biostatistics; 2012 Jan; 13(1):179-92. PubMed ID: 21914729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of the 1990 Hong Kong legislation for restriction on sulfur content in fuel.
    Wong CM; Rabl A; Thach TQ; Chau YK; Chan KP; Cowling BJ; Lai HK; Lam TH; McGhee SM; Anderson HR; Hedley AJ
    Res Rep Health Eff Inst; 2012 Aug; (170):5-91. PubMed ID: 23316618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal and repeated cross-sectional cluster-randomization designs using mixed effects regression for binary outcomes: bias and coverage of frequentist and Bayesian methods.
    Localio AR; Berlin JA; Have TR
    Stat Med; 2006 Aug; 25(16):2720-36. PubMed ID: 16345043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimation of relative risk and prevalence ratio.
    Savu A; Liu Q; Yasui Y
    Stat Med; 2010 Sep; 29(22):2269-81. PubMed ID: 20564738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimation in regression models for longitudinal binary data with outcome-dependent follow-up.
    Fitzmaurice GM; Lipsitz SR; Ibrahim JG; Gelber R; Lipshultz S
    Biostatistics; 2006 Jul; 7(3):469-85. PubMed ID: 16428260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trial of penicillamine in advanced primary biliary cirrhosis.
    Dickson ER; Fleming TR; Wiesner RH; Baldus WP; Fleming CR; Ludwig J; McCall JT
    N Engl J Med; 1985 Apr; 312(16):1011-5. PubMed ID: 3885033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival model predictive accuracy and ROC curves.
    Heagerty PJ; Zheng Y
    Biometrics; 2005 Mar; 61(1):92-105. PubMed ID: 15737082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Asymptomatic primary biliary cirrhosis. Presentation, histology, and results with D-penicillamine.
    Fleming CR; Ludwig J; Dickson ER
    Mayo Clin Proc; 1978 Sep; 53(9):587-93. PubMed ID: 355732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flexible regression models for rate differences, risk differences and relative risks.
    Donoghoe MW; Marschner IC
    Int J Biostat; 2015 May; 11(1):91-108. PubMed ID: 25781711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival trial design and monitoring using historical controls.
    Wu J; Xiong X
    Pharm Stat; 2016 Sep; 15(5):405-11. PubMed ID: 27307025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance of the modified Poisson regression approach for estimating relative risks from clustered prospective data.
    Yelland LN; Salter AB; Ryan P
    Am J Epidemiol; 2011 Oct; 174(8):984-92. PubMed ID: 21841157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fully parametric and semi-parametric regression models for common events with covariate measurement error in main study/validation study designs.
    Spiegelman D; Casella M
    Biometrics; 1997 Jun; 53(2):395-409. PubMed ID: 9192443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of odds ratio or relative risk to measure a treatment effect in clinical trials with multiple correlated binary outcomes: data from the NINDS t-PA stroke trial.
    Lu M; Tilley BC;
    Stat Med; 2001 Jul; 20(13):1891-901. PubMed ID: 11427947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective trial of D-penicillamine in primary biliary cirrhosis.
    Matloff DS; Alpert E; Resnick RH; Kaplan MM
    N Engl J Med; 1982 Feb; 306(6):319-26. PubMed ID: 7033789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimation of group means when adjusting for covariates in generalized linear models.
    Qu Y; Luo J
    Pharm Stat; 2015; 14(1):56-62. PubMed ID: 25406099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficient estimation for patient-specific rates of disease progression using nonnormal linear mixed models.
    Zhang P; Song PX; Qu A; Greene T
    Biometrics; 2008 Mar; 64(1):29-38. PubMed ID: 17501938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.